The Chennai Angels — 2022 Investments
7 investments dated 2022 · listed companies and verified rows first · show all
Avammune is a biotech company developing novel therapeutic modalities to address hard-to-treat cancers with distinct mechanisms of action.
AI & Machine LearningBiotechDeep TechMedical Devices
Arun(Founder | CEO)Aditya(Founder | CSO)Srinivasan(Founder | Director)
Co-investors1CrowdCapital2BShastra VCIvyCap Ventures
CultYvate provides IoT-enabled field execution and data-driven farming services to help smallholder farmers improve yields, conserve water, and generate carbon credits.
AgTechAI & Machine LearningClimate TechIoTIndia, IN
Mallesh T M(Founder)inSudarshan B S(Founder)in
Co-investorsSunICON Ventures
Degpeg operates a multistreaming platform that lets content creators and brands broadcast live to 30+ social platforms simultaneously, with a focus on live commerce.
Creator EconomyE-commerceMedia & EntertainmentRetail TechSaaS
Vipul Jain(Founder)in
Co-investorsExpert DOJOVenture Catalysts
My3DMeta turns a single uploaded photo into 3D models, jewelry, and 3D-printed figurines, using AI generation combined with human artist refinement.
AI & Machine LearningConsumerE-commerce
Co-investorsDholakia VenturesHyderabad AngelsAccelNest
Personalised pet products tailored to a dog's breed and health, delivered to the door
James Davidson(Founder)in
Co-investorsArts AllianceOctopus Ventures
TurboHire provides enterprise hiring software and services.
AI & Machine LearningEnterprise SoftwareHR TechSaaSHyderabad, IN
Deepak Agrawal(CEO & Co-founder)inGaurav Kumar(CTO & Co-founder)inRakesh Ranjan Nayak(CIO & Co-founder)in
Co-investorsHyderabad AngelsIvyCap VenturesPentathlon VenturesMumbai Angels
Twixor provides an agentic AI platform that enables businesses to build intelligent customer interactions using prompt-based configuration and contextual memory.
AI & Machine LearningEnterprise SoftwareMarketing TechSaaS
Co-investorsAxilor VenturesSeason Two Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

















